If you liked this article you might like

EpiPen Competitor Auvi-Q Will Return in February, but It'll Cost Insurance Companies Big Bucks
Biotech Premarket Movers: SGMO, IPXL, PTLA
Mylan Crushed by Trump, Cigna and CVS -- All In Two Days
CVS Is the Latest to Rock Mylan's EpiPen Empire